Search research articles
Contact Us
Filters
Showing results (101-110 of 148) with videos related to
Page
of 15
Sort By:
The Journal of Organic Chemistry
|
July 8, 2015
Synthesis of Biologically Active Piperidine Metabolites of Clopidogrel: Determination of Structure and Analyte Development
Scott A Shaw, Balu Balasubramanian, Samuel Bonacorsi, et al.
The Journal of Organic Chemistry
|
September 3, 2015
Correction to "Synthesis of Biologically Active Piperidine Metabolites of Clopidogrel: Determination of Structure and Analyte Development"
Scott A Shaw, Balu Balasubramanian, Samuel Bonacorsi, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 11, 2015
BMS-871: a novel orally active pan-Notch inhibitor as an anticancer agent
Weifang Shan, Aaron Balog, Claude Quesnelle, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent
Upender Velaparthi, Chetan Padmakar Darne, Jayakumar Warrier, et al.
Age and Ageing
|
May 21, 2026
Frailty and intrinsic capacity: integrating complementary concepts to promote healthy ageing and transformation of care
Matteo Cesari, Marco Canevelli, Jotheeswaran Amuthavalli Thiyagarajan, et al.
Journal of Medicinal Chemistry
|
May 29, 2024
Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure
Jeremy M Richter, Prashantha Gunaga, Navnath Yadav, et al.
Journal of Medicinal Chemistry
|
September 26, 2009
Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development
Mark D Wittman, Joan M Carboni, Zheng Yang, et al.
Journal of Medicinal Chemistry
|
May 28, 2020
Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species
Wu Yang, Yufeng Wang, Amy Lai, et al.
Journal of Medicinal Chemistry
|
August 31, 2022
The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation
Alicia Regueiro-Ren, Sing-Yuen Sit, Yan Chen, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials
T G Murali Dhar, Hai-Yun Xiao, Jenny Xie, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 148) with videos related to
Sort By:
Page
of 15
The Journal of Organic Chemistry
|
July 8, 2015
Synthesis of Biologically Active Piperidine Metabolites of Clopidogrel: Determination of Structure and Analyte Development
Scott A Shaw, Balu Balasubramanian, Samuel Bonacorsi, et al.
The Journal of Organic Chemistry
|
September 3, 2015
Correction to "Synthesis of Biologically Active Piperidine Metabolites of Clopidogrel: Determination of Structure and Analyte Development"
Scott A Shaw, Balu Balasubramanian, Samuel Bonacorsi, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 11, 2015
BMS-871: a novel orally active pan-Notch inhibitor as an anticancer agent
Weifang Shan, Aaron Balog, Claude Quesnelle, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent
Upender Velaparthi, Chetan Padmakar Darne, Jayakumar Warrier, et al.
Age and Ageing
|
May 21, 2026
Frailty and intrinsic capacity: integrating complementary concepts to promote healthy ageing and transformation of care
Matteo Cesari, Marco Canevelli, Jotheeswaran Amuthavalli Thiyagarajan, et al.
Journal of Medicinal Chemistry
|
May 29, 2024
Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure
Jeremy M Richter, Prashantha Gunaga, Navnath Yadav, et al.
Journal of Medicinal Chemistry
|
September 26, 2009
Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development
Mark D Wittman, Joan M Carboni, Zheng Yang, et al.
Journal of Medicinal Chemistry
|
May 28, 2020
Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species
Wu Yang, Yufeng Wang, Amy Lai, et al.
Journal of Medicinal Chemistry
|
August 31, 2022
The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation
Alicia Regueiro-Ren, Sing-Yuen Sit, Yan Chen, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials
T G Murali Dhar, Hai-Yun Xiao, Jenny Xie, et al.
Page
of 15